News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
693,227 Results
Type
Article (41192)
Company Profile (290)
Press Release (651745)
Section
Business (204792)
Career Advice (1997)
Deals (35480)
Drug Delivery (89)
Drug Development (81383)
Employer Resources (168)
FDA (16264)
Job Trends (14866)
News (346364)
Policy (32631)
Tag
Academia (2611)
Alliances (49542)
Alzheimer's disease (1257)
Approvals (16202)
Artificial intelligence (144)
Bankruptcy (353)
Best Places to Work (11612)
Biotechnology (209)
Breast cancer (189)
Cancer (1333)
Cardiovascular disease (107)
Career advice (1665)
Cell therapy (274)
Clinical research (64938)
Collaboration (445)
Compensation (245)
COVID-19 (2557)
C-suite (109)
Data (1367)
Diabetes (163)
Diagnostics (6220)
Earnings (85034)
Employer resources (146)
Events (110505)
Executive appointments (364)
FDA (16896)
Funding (414)
Gene therapy (195)
GLP-1 (596)
Government (4350)
Healthcare (18803)
Infectious disease (2646)
Inflammatory bowel disease (110)
Interviews (310)
IPO (16371)
Job creations (3642)
Job search strategy (1420)
Layoffs (417)
Legal (7889)
Lung cancer (189)
Manufacturing (194)
Medical device (13363)
Medtech (13368)
Mergers & acquisitions (19240)
Metabolic disorders (433)
Neuroscience (1569)
NextGen Class of 2024 (6575)
Non-profit (4496)
Northern California (1643)
Obesity (252)
Opinion (183)
Patents (115)
People (56605)
Phase I (20235)
Phase II (28602)
Phase III (21282)
Pipeline (504)
Postmarket research (2573)
Preclinical (8669)
Radiopharmaceuticals (241)
Rare diseases (253)
Real estate (5924)
Regulatory (21761)
Research institute (2359)
Resumes & cover letters (349)
Southern California (1424)
Startups (3610)
United States (14793)
Vaccines (561)
Weight loss (177)
Date
Last 7 days (682)
Last 30 days (2371)
Last 365 days (35433)
2024 (34631)
2023 (40336)
2022 (51453)
2021 (55975)
2020 (54310)
2019 (46846)
2018 (35280)
2017 (32367)
2016 (31821)
2015 (37900)
2014 (31611)
2013 (26753)
2012 (28951)
2011 (29569)
2010 (27629)
Location
Africa (719)
Arizona (196)
Asia (37725)
Australia (6211)
California (3692)
Canada (1410)
China (290)
Colorado (171)
Connecticut (171)
Europe (81168)
Florida (513)
Georgia (130)
Illinois (374)
Indiana (218)
Kansas (97)
Maryland (616)
Massachusetts (2889)
Michigan (169)
Minnesota (289)
New Jersey (1067)
New York (1051)
North Carolina (736)
Northern California (1643)
Ohio (144)
Pennsylvania (903)
South America (1103)
Southern California (1424)
Texas (533)
Utah (106)
Washington State (394)
693,227 Results for "tissue genesis inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™
Axogen, Inc. announces the launch of its newest product, Avive+ Soft Tissue Matrix™. Avive+™ is intended for use as a soft tissue barrier and is a resorbable, multi-layer amniotic membrane allograft that provides temporary protection and tissue separation during the critical phase of peripheral nerve healing.
June 24, 2024
·
6 min read
Press Releases
Genesis Innovation Group Launches New Website and Branding to Support New Market Growth
November 26, 2024
·
2 min read
Press Releases
Genesis Therapeutics Expands Leadership Team with Appointments of Chief Scientific Officer, SVP of Engineering, and Board Chairman
December 11, 2024
·
4 min read
Press Releases
Genesis Therapeutics Announces New Equity Investment and Collaboration with NVIDIA to Optimize Key Computational Methods for AI-powered Drug Discovery
November 13, 2024
·
2 min read
Biotech Bay
Adela to Present Data Supporting Use of its Tissue-Agnostic MRD Assay for Recurrence Prediction and Monitoring in Patients with Head & Neck Cancer at the American Society of Clinical Oncology 2024 Meeting
Adela, Inc will present results demonstrating the ability of its tissue-agnostic MRD assay to predict recurrence in head & neck cancer, during an Oral Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting on June 3, 2024.
May 30, 2024
·
4 min read
BioMidwest
Celebrating Its Fifth Anniversary, Genesis Reference Laboratories Announces Testing Upgrades
Genesis Reference Laboratories, a leading diagnostics laboratory, is pleased to announce upgrades to its testing menus.
February 8, 2024
·
3 min read
Business
Tim Czartoski Appointed as CEO of Genesis Innovation Group
Genesis Innovation Group is excited to announce the appointment of Tim Czartoski as Chief Executive Officer effective April 1, 2024, and serving in an advisory role until that time.
January 22, 2024
·
3 min read
Press Releases
Santhera Enters into an Exclusive Distribution Agreement with GENESIS Pharma for AGAMREE® (Vamorolone) in Central and Eastern Europe
September 10, 2024
·
6 min read
Biotech Bay
Adela to Present Data from Tissue-Agnostic MRD Assay at the American Association for Cancer Research Annual Meeting 2024
Adela, Inc. today announced data will be presented at the American Association for Cancer Research (AACR) Annual Meeting from April 5-10, 2024 from its tissue-agnostic minimal residual disease (MRD) assay.
March 19, 2024
·
3 min read
Deals
Stryker Announces Definitive Agreement to Acquire Artelon, Inc., Offering a Range of Soft Tissue Fixation Solutions for Orthopaedic Surgeons
Stryker announced the signing of a definitive agreement to acquire all of the issued and outstanding shares of Artelon, a privately held company specializing in innovative soft tissue fixation products for foot and ankle and sports medicine procedures.
June 3, 2024
·
2 min read
1 of 69,323
Next
